October 2024 - The recipients of the three 2024 iCMLf Prizes received their medals at the recent ESH-iCMLf 26th John Goldman Conference on CML: Biology and Therapy. During their acceptance speeches they shared insights into their incredible work which has significantly shaped the way we understand and treat CML today.

The keynote presentations of the 2024 prize recipients are now available to view on the iCMLf website, and they reflect the innovation, compassion, and dedication of all three prize winners across CML research, treatment, and patient advocacy.

You can listen to Professor Neil Shah’s personal view on the challenges of treatment resistance, Professor Jeff Lipton exploring the therapeutic goals of CML from the perspectives of both physicians and patients, and Viji Venkatesh share her powerful account of collaborative efforts in CML patient support and community-building.

View keynote presentations from the 2024 prize recipients

Take a look at these inspiring lectures from the 2024 award winners – who will share with us their experiences, personal perspectives and thoughts on their ground-breaking work and career in CML.

• 2024 iCMLf Rowley Prize
  Awardee: Professor Neil Shah (San Francisco, USA)
  Keynote presentation: What have we learned from treatment resistance?

• 2024 iCMLf Goldman Prize
  Awardee: Professor Jeff Lipton (Toronto, Canada)
  Keynote presentation: What is the goal of CML therapy? A physician’s impression of a patient’s impression and are we missing the boat?
  
  
• 2024 iCMLf Prize
  Awardee: Viji Venkatesh (Mumbai, India)
  Keynote presentation: It takes a village…the Saga of the reinvention of CML

View the 2024 iCMLf Prize keynote presentations

Nominations for the 2025 awards will be open soon, so get ready to share your thoughts on the leaders in CML who have made the largest contributions to understanding and managing CML globally.